Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 4/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 4/20 | 0.32 |
| ▸ | KDR | P35968 | 4/20 | 0.32 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19896380 | 0.91 | OPRM1 (0.40) | OPRD1OPRM1OPRK1OPRL1BRD4 | |
| SCHEMBL19896310 | 0.91 | OPRM1 (0.40) | OPRD1OPRM1OPRK1OPRL1BRD4 | |
| SCHEMBL19896318 | 0.81 | CNR2 (0.34) | OPRD1BRD4PDGFRBKDRESR1 | |
| SCHEMBL19896308 | 0.81 | BRD4 (0.38) | BRD4PDGFRBKDRESR1ESR2 | |
| SCHEMBL19896281 | 0.75 | OPRM1 (0.38) | OPRD1OPRM1OPRK1OPRL1BRD4 | |
| SCHEMBL19896296 | 0.74 | CNR2 (0.46) | — | |
| SCHEMBL19896383 | 0.74 | MAPT (0.45) | OPRD1PDGFRBKDRESR1ESR2 | |
| Hydrochloric Acid SCHEMBL19896465 | 0.74 | KDM4E (0.40) | OPRD1OPRM1OPRK1OPRL1BRD4 | |
| SCHEMBL19896356 | 0.72 | CNR2 (0.50) | — | |
| SCHEMBL19896452 | 0.72 | CNR2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421779-B2 | Carbazole compound having anti-virus activity | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2019-09-24 | — | — | US | disclosed |
| US-20180057527-A1 | CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180057527-A1 | CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY | ZC3HAV1, ZC3HAV1L, GTF3C3 | OPRD1 3087/4885OPRM1 4146/4885OPRK1 2750/4885 |
| US-10421779-B2 | Carbazole compound having anti-virus activity | ZC3HAV1, ZC3HAV1L, GTF3C3 | OPRD1 3087/4885OPRM1 4146/4885OPRK1 2750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.